Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Retsky is Editor with Romano Demicheli of a Springer-Nature book published July 2017 (Perioperative Inflammation as Triggering Origin of Metastasis Development). After diagnosis of stage IIIc colon cancer in 1994, he was the first person to use what is now called metronomic chemotherapy. He is a founder and was on the Board of Directors of the Colon Cancer Alliance.